ASH 2017: CLL Combination Therapy News

ASH 2017: CLL Combination Therapy News

P2Professional

2 years
1,057 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Can todays medicines be used together to treat CLL more effectively? CLL expert Dr. Michael Choi of UC San Diego Moores Cancer Center joins Patient Powers Andrew Schorr at the 2017 American Society of Hematology (ASH) conference. Dr. Choi provides an update on current medicines and discusses promising combination therapies for CLL, including research into combining ibrutinib (Imbruvica) and venetoclax (Venclexta).
Up Next Autoplay